BOTHELL, Wash., Oct. 17 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that its new cardiac rehab system, Q- Tel RMS(R) 3.0, now has seamless connectivity with LUMEDX CardioWellness(TM) data management software.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
The integration of rehabilitation data from the Q-Tel RMS 3.0 system into CardioWellness enables the best possible treatment decisions. The combination allows caregivers to seamlessly integrate data from the Q-Tel RMS 3.0 rehabilitation system into CardioWellness, creating a comprehensive diagnosis and treatment plan tuned specifically to the patient’s gender specific needs. By applying this gender-specific understanding of the patient’s disease state to the rehabilitation treatment, outcomes can be improved.
“Cardiac Science is dedicated to helping its customers improve their workflows and improve access to data, facilitating the best possible treatment decisions,” said René Mitchell, director of diagnostic marketing at Cardiac Science. “In response to feedback from clinicians, the Q-Tel RMS 3.0 features enhanced connectivity capabilities to improve rehab center workflow, while maintaining the heritage of reliability and high performance of the Q-Tel family of rehabilitation management systems. We believe that this collaboration with LUMEDX will improve patient care and better meet the needs of our customers.”
“CardioWellness can help facilities grow their gender-specific cardiovascular care programs with its sophisticated database for tracking patients from risk assessment through treatment,” said Randy Marc Lasnick, director of marketing at LUMEDX Corporation. “Research has shown that gender- specific care can provide patients with better outcomes. We believe that by providing a direct link between CardioWellness and Q-Tel RMS 3.0, the leading cardiac rehabilitation system, we can provide greater value to these facilities by bringing an added layer of critical rehab data into the clinical decision making process.”
Frost & Sullivan, the global growth consulting company, has awarded Cardiac Science its 2007 award for Global Excellence in ECG Monitoring, recognizing Cardiac Science’s superior leadership and vision to provide superior healthcare solutions in the cardiac monitoring market.
For more information about the Q-Tel RMS 3.0, please call 800.679.8703.
About LUMEDX
Founded in 1990, LUMEDX is the market leader in developing end-to-end cardiovascular information and imaging systems. Providing consulting services, training, and the CardioStar(TM) software suite-the most comprehensive suite of fully integrated cardiovascular information tools-LUMEDX delivers complete clinical and business solutions for heart centers.
About CardioWellness
CardioWellness is a comprehensive set of tools and support programs to help heart centers grow their own successful gender-specific CV centers. CardioWellness recognizes the differences in presentation, diagnostic testing, risk assessment, and outcomes for men and women. These differences are built into the way patients are diagnosed, treated, and tracked throughout the continuum of care.
About Q-Tel RMS 3.0
The Q-Tel RMS system is a state-of-the-art, comprehensive cardiac monitoring and data management system developed to meet the needs of cardiac rehabilitation programs. Designed with efficient workflow and integration to EMR and HIS systems in mind, the Q-Tel family of Rehabilitation Management Systems is designed to enable the best possible treatment decisions.
About Cardiac Science Corporation
Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark; and Manchester, United Kingdom.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “intend,” anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include those that infer or imply that our alliance with LUMEDX will contribute to our success in the marketplace, and that our sales and profits derived from our cardiac rehabilitation and monitoring devices and our other products will increase as a result. These statements, including their underlying assumptions, are subject to risks and uncertainties and are not guarantees of future performance. Other risk factors that could cause or contribute to such varying results are described in our annual report for the year ended December 31, 2006, filed with the Securities and Exchange Commission.
The statements in this press release speak as of the date of the release, and Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; or Investors, Douglas Sherk or Jenifer
Kirtland, +1-415-896-6820, or Media, Jen Saunders, +1-646-201-5431, all of
EVC Group, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com//
